124 related articles for article (PubMed ID: 2907954)
1. Dopaminergic drugs in the cationic form interact with D2 dopamine receptors.
Miller DD; Harrold M; Wallace RA; Wallace LJ; Uretsky NJ
Trends Pharmacol Sci; 1988 Aug; 9(8):282-4. PubMed ID: 2907954
[No Abstract] [Full Text] [Related]
2. [Current developments in the pharmacology of the dopaminergic receptors. III].
Nechifor M; Lucaci L
Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):510, 516, 566. PubMed ID: 2576889
[No Abstract] [Full Text] [Related]
3. [Current developments in the pharmacology of dopaminergic receptors (I)].
Nechifor M; Lucaci L
Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):143-4. PubMed ID: 2573121
[No Abstract] [Full Text] [Related]
4. Peripheral dopaminergic nerves.
Bell C
Pharmacol Ther; 1989; 44(2):157-79. PubMed ID: 2577510
[No Abstract] [Full Text] [Related]
5. A functional test identifies dopamine agonists selective for D3 versus D2 receptors.
Sautel F; Griffon N; Lévesque D; Pilon C; Schwartz JC; Sokoloff P
Neuroreport; 1995 Jan; 6(2):329-32. PubMed ID: 7756621
[TBL] [Abstract][Full Text] [Related]
6. The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs.
Memo M; Missale C; Pizzi M; Spano PF
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():458A-459A. PubMed ID: 1354049
[No Abstract] [Full Text] [Related]
7. Stimulation of dopamine D1 receptors by the D2 agonist CV 205-502 in bovine retina homogenates.
de Raad S; Schorderet M
Biochem Pharmacol; 1992 Apr; 43(8):1882-4. PubMed ID: 1349479
[No Abstract] [Full Text] [Related]
8. Dopaminergic drug-receptor interactions.
Scott JE
Trends Pharmacol Sci; 1989 Jan; 10(1):14-5. PubMed ID: 2574508
[No Abstract] [Full Text] [Related]
9. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia.
Coward D; Dixon K; Enz A; Shearman G; Urwyler S; White T; Karobath M
Psychopharmacol Bull; 1989; 25(3):393-7. PubMed ID: 2576320
[TBL] [Abstract][Full Text] [Related]
10. [Current developments in the pharmacology of dopaminergic receptors (II)].
Nechifor M
Rev Med Chir Soc Med Nat Iasi; 1989; 93(2):393-4. PubMed ID: 2573123
[No Abstract] [Full Text] [Related]
11. D-2 dopamine autoreceptor selective drugs: do they really exist?
Drukarch B; Stoof JC
Life Sci; 1990; 47(5):361-76. PubMed ID: 1975636
[TBL] [Abstract][Full Text] [Related]
12. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area.
Mercuri NB; Calabresi P; Bernardi G
Life Sci; 1992; 51(10):711-8. PubMed ID: 1355254
[TBL] [Abstract][Full Text] [Related]
13. The dopaminergic actions of B-HT 920.
Kulkarni SK; Chopra K
Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):99-102. PubMed ID: 1969506
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptors: classification, properties and drug development.
Beart PM
Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):511-5. PubMed ID: 2569952
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor binding properties of [3H]U-86170, a dopamine receptor agonist.
Lahti RA; Evans DL; Figur LM; Carrigan KJ; Moon MW; Hsi RS
Eur J Pharmacol; 1991 Sep; 202(2):289-91. PubMed ID: 1687034
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of non-hydroxylated and ether derivatives of the potent D2-selective agonist N-0437.
Jansen JM; den Daas I; Rollema H; Swart PJ; Tepper PG; de Vries JB; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1991 Feb; 343(2):134-42. PubMed ID: 1676829
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease: sites of action and implications for the pathogenesis of dyskinesias.
Robertson HA
Can J Neurol Sci; 1992 Feb; 19(1 Suppl):147-52. PubMed ID: 1349263
[TBL] [Abstract][Full Text] [Related]
18. Physiology and pharmacology of dopamine D2-receptors: their implications in dopamine-substitute therapy for Parkinson's disease.
Mercuri NB; Calabresi P; Bernardi G
Neurology; 1989 Aug; 39(8):1106-8. PubMed ID: 2569697
[No Abstract] [Full Text] [Related]
19. Dopamine receptor agonists and antagonists.
Kohli JD
Proc West Pharmacol Soc; 1990; 33():21-7. PubMed ID: 1980362
[No Abstract] [Full Text] [Related]
20. Synthesis and dopaminergic features of six novel 3-arylpiperidines.
Kostic-Rajacic A; Soskic V; Joksimovic J
Boll Chim Farm; 1998 Nov; 137(10):417-21. PubMed ID: 10025971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
